Cargando…
Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparum LSA1 and LSAP2 for Efficacy against Liver-Stage Malaria
Despite promising progress in malaria vaccine development in recent years, an efficacious subunit vaccine against Plasmodium falciparum remains to be licensed and deployed. Cell-mediated protection from liver-stage malaria relies on a sufficient number of antigen-specific T cells reaching the liver...
Autores principales: | Halbroth, Benedict R., Sebastian, Sarah, Salman, Ahmed M., Ulaszewska, Marta, Gola, Anita, Longley, Rhea J., Janse, Chris J., Khan, Shahid M., Hill, Adrian V. S., Spencer, Alexandra J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977128/ https://www.ncbi.nlm.nih.gov/pubmed/31740525 http://dx.doi.org/10.1128/IAI.00573-19 |
Ejemplares similares
-
Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine
por: Longley, Rhea J., et al.
Publicado: (2017) -
Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of Mice
por: Longley, Rhea J., et al.
Publicado: (2015) -
The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines
por: Espinosa, Diego A., et al.
Publicado: (2017) -
Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors
por: Atcheson, Erwan, et al.
Publicado: (2018) -
Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children
por: Murungi, Linda M., et al.
Publicado: (2016)